AG˹ٷ

STOCK TITAN

Quanex Building Products Announces Second Quarter 2025 Results and Reaffirms Full Year 2025 Guidance

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Quanex Building Products (NYSE:NX) reported strong Q2 2025 results with net sales of $452.5M, up 70% YoY, primarily driven by the Tyman acquisition. The company's gross margin improved to 29.0% from 24.9%, while net income reached $20.5M. The Tyman integration is progressing ahead of schedule, with cost synergy targets increased from $30M to $45M. European Fenestration segment showed volume growth, though North American sales declined 5.5%. The company maintained its FY2025 guidance, projecting net sales of $1.84-1.86B and Adjusted EBITDA of $270-280M. During Q2, Quanex repurchased 1.26M shares for $23.5M at an average price of $18.66. The company's leverage ratio decreased to 3.2x, with total debt of $785M and liquidity of $289M as of April 30, 2025.
Quanex Building Products (NYSE:NX) ha riportato solidi risultati nel secondo trimestre 2025 con vendite nette di 452,5 milioni di dollari, in aumento del 70% rispetto all'anno precedente, principalmente grazie all'acquisizione di Tyman. Il margine lordo dell'azienda è migliorato al 29,0% dal 24,9%, mentre l'utile netto ha raggiunto i 20,5 milioni di dollari. L'integrazione di Tyman procede più rapidamente del previsto, con l'obiettivo di sinergie di costo aumentato da 30 a 45 milioni di dollari. Il segmento European Fenestration ha mostrato una crescita dei volumi, mentre le vendite in Nord America sono diminuite del 5,5%. L'azienda ha confermato le previsioni per l'intero anno 2025, prevedendo vendite nette tra 1,84 e 1,86 miliardi di dollari e un EBITDA rettificato tra 270 e 280 milioni di dollari. Nel secondo trimestre, Quanex ha riacquistato 1,26 milioni di azioni per 23,5 milioni di dollari a un prezzo medio di 18,66 dollari. Il rapporto di leva finanziaria è sceso a 3,2x, con un debito totale di 785 milioni di dollari e una liquidità di 289 milioni di dollari al 30 aprile 2025.
Quanex Building Products (NYSE:NX) reportó sólidos resultados en el segundo trimestre de 2025 con ventas netas de 452,5 millones de dólares, un aumento del 70% interanual, impulsado principalmente por la adquisición de Tyman. El margen bruto de la compañía mejoró al 29,0% desde el 24,9%, mientras que el ingreso neto alcanzó los 20,5 millones de dólares. La integración de Tyman avanza antes de lo previsto, con objetivos de sinergias de costos aumentados de 30 a 45 millones de dólares. El segmento European Fenestration mostró crecimiento en volumen, aunque las ventas en Norteamérica disminuyeron un 5,5%. La empresa mantuvo su guía para el año fiscal 2025, proyectando ventas netas de 1,84-1,86 mil millones de dólares y un EBITDA ajustado de 270-280 millones de dólares. Durante el segundo trimestre, Quanex recompró 1,26 millones de acciones por 23,5 millones de dólares a un precio promedio de 18,66 dólares. La ratio de apalancamiento de la compañía disminuyó a 3,2x, con una deuda total de 785 millones de dólares y una liquidez de 289 millones de dólares al 30 de abril de 2025.
Quanex Building Products (NYSE:NX)� 2025� 2분기� 순매� 4� 5,250� 달러� 전년 대� 70% 증가� 강력� 실적� 발표했습니다. 이는 주로 Tyman 인수 덕분입니�. 회사� 총이익률은 24.9%에서 29.0%� 개선되었으며, 순이익은 2,050� 달러� 달했습니�. Tyman 통합은 예정보다 빠르� 진행 중이�, 비용 시너지 목표� 3,000� 달러에서 4,500� 달러� 상향 조정되었습니�. 유럽 창호 부문은 물량 증가� 보였으나 북미 매출은 5.5% 감소했습니다. 회사� 2025 회계연도 가이던스를 유지하며 순매� 18� 4천만~18� 6천만 달러, 조정 EBITDA 2� 7,000만~2� 8,000� 달러� 예상하고 있습니다. 2분기 동안 Quanex� 평균 주당 18.66달러� 126� 주를 2,350� 달러� 재매입했습니�. 2025� 4� 30� 기준 부� 총액은 7� 8,500� 달러, 유동성은 2� 8,900� 달러이며, 레버리지 비율은 3.2배로 감소했습니다.
Quanex Building Products (NYSE:NX) a publié de solides résultats pour le deuxième trimestre 2025 avec un chiffre d'affaires net de 452,5 millions de dollars, en hausse de 70 % sur un an, principalement grâce à l'acquisition de Tyman. La marge brute de l'entreprise s'est améliorée à 29,0 % contre 24,9 %, tandis que le bénéfice net a atteint 20,5 millions de dollars. L'intégration de Tyman progresse plus rapidement que prévu, avec un objectif de synergies de coûts relevé de 30 à 45 millions de dollars. Le segment European Fenestration a enregistré une croissance des volumes, bien que les ventes en Amérique du Nord aient diminué de 5,5 %. La société a maintenu ses prévisions pour l'exercice 2025, prévoyant un chiffre d'affaires net compris entre 1,84 et 1,86 milliard de dollars et un EBITDA ajusté de 270 à 280 millions de dollars. Au cours du deuxième trimestre, Quanex a racheté 1,26 million d'actions pour 23,5 millions de dollars à un prix moyen de 18,66 dollars. Le ratio d'endettement de la société a diminué à 3,2x, avec une dette totale de 785 millions de dollars et une liquidité de 289 millions de dollars au 30 avril 2025.
Quanex Building Products (NYSE:NX) meldete starke Ergebnisse für das zweite Quartal 2025 mit Nettoumsätzen von 452,5 Mio. USD, was einem Anstieg von 70 % gegenüber dem Vorjahr entspricht, hauptsächlich getrieben durch die Übernahme von Tyman. Die Bruttomarge verbesserte sich von 24,9 % auf 29,0 %, während der Nettogewinn 20,5 Mio. USD erreichte. Die Integration von Tyman verläuft schneller als geplant, wobei die Kostensynergieziele von 30 Mio. USD auf 45 Mio. USD erhöht wurden. Das Segment European Fenestration verzeichnete ein Volumenwachstum, während die Verkäufe in Nordamerika um 5,5 % zurückgingen. Das Unternehmen bestätigte seine Prognose für das Geschäftsjahr 2025 und erwartet Nettoumsätze von 1,84 bis 1,86 Mrd. USD sowie ein bereinigtes EBITDA von 270 bis 280 Mio. USD. Im zweiten Quartal kaufte Quanex 1,26 Mio. Aktien für 23,5 Mio. USD zu einem Durchschnittspreis von 18,66 USD zurück. Die Verschuldungsquote sank auf 3,2x, mit einer Gesamtschuld von 785 Mio. USD und einer Liquidität von 289 Mio. USD zum 30. April 2025.
Positive
  • Tyman acquisition cost synergy target increased to $45M from original $30M target
  • Net sales increased 70% YoY to $452.5M in Q2 2025
  • Gross margin improved to 29.0% from 24.9% YoY
  • Volume growth achieved in European Fenestration segment
  • Strong liquidity position of $289M as of April 30, 2025
  • Active share repurchase program with $23.5M spent in Q2
Negative
  • North American Fenestration segment sales declined 5.5%
  • Net income per diluted share decreased to $0.44 from $0.46 YoY
  • Free cash flow declined to $13.6M from $25.5M YoY
  • High leverage with total debt of $785M
  • Six-month net income dropped to $5.6M from $21.6M YoY

Insights

Quanex reports solid Q2 results with improved margins, faster-than-expected Tyman integration, and increased synergy targets despite mixed volume performance.

Quanex's Q2 2025 results demonstrate significant topline growth, with revenue increasing 70% year-over-year to $452.5 million, primarily driven by the Tyman acquisition that closed in August 2024. The acquisition's integration is progressing ahead of schedule, with management increasing cost synergy targets from $30 million to approximately $45 million.

From a profitability perspective, gross margin expanded 410 basis points to 29.0% compared to 24.9% in Q2 2024. This translated to adjusted EBITDA of $61.9 million, representing a 54.8% increase from the prior year, though adjusted EBITDA margin contracted slightly to 13.7% from 15.0%.

Underlying business trends show a mixed picture. Excluding Tyman, organic sales declined 1.4%, with North American Fenestration sales down 5.5%, highlighting ongoing demand challenges in the residential construction market. However, European Fenestration showed encouraging 7.9% volume growth when excluding foreign exchange impacts.

The company's leverage position is worth monitoring, with total debt at $785 million and a net debt to LTM adjusted EBITDA ratio of 3.2x. For covenant purposes, this ratio stands at 2.7x, comfortably below the 3.75x requirement. Management is prioritizing debt reduction alongside share repurchases, having bought back 1.26 million shares for $23.5 million during the quarter.

The sequential revenue improvement (March 6% higher than February, April 9% higher than March) indicates normal seasonality is unfolding as expected. Management has reaffirmed full-year 2025 guidance of $1.84-1.86 billion in revenue and $270-280 million in adjusted EBITDA, suggesting confidence in continued seasonal improvement through summer despite macroeconomic headwinds.

Seasonal Uptick Unfolding as Expected
Volume Growth in European Fenestration Segment
Results Again Lifted by Contribution from Tyman Acquisition
Tyman Integration Ahead of Timeline
Cost Synergy Target Increased to ~$45 Million

HOUSTON, June 05, 2025 (GLOBE NEWSWIRE) -- (NYSE:NX) (“Quanex� or the “Company�) today announced its results for the three months ended April 30, 2025.

The Company reported the following selected financial results:

Three Months Ended April 30,Six Months Ended April 30,
($ in millions, except per share data)2025202420252024
Net Sales$452.5$266.2$852.5$505.4
Gross Margin$131.4$66.2$223.7$117.7
Gross Margin %29.0%24.9%26.2%23.3%
Net Income$20.5$15.4$5.6$21.6
Diluted EPS$0.44$0.46$0.12$0.65
Adjusted Net Income$27.9$24.0$36.8$32.3
Adjusted Diluted EPS$0.60$0.73$0.79$0.98
Adjusted EBITDA$61.9$40.0$100.5$59.3
Adjusted EBITDA Margin %13.7%15.0%11.8%11.7%
Cash Provided by Operating Activities$28.5$33.1$16.0$36.9
Free Cash Flow$13.6$25.5($10.6)$19.8
(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and reconciliation tables for additional information)

George Wilson, Chairman, President and Chief Executive Officer, commented, “Our results for the second quarter of 2025 came in as expected and reflected normal seasonality in our business. Revenue in March was approximately 6% higher than February and revenue in April was approximately 9% higher than March. It was also encouraging to see volume growth in our European Fenestration segment during the second quarter of 2025. We continue to be pleased with the integration of Tyman, and are now confident we will deliver approximately $45 million in cost synergies over time, compared to our original target of $30 million within the first two years post-acquisition. On a run-rate basis, we see a path to achieving the original $30 million cost synergy target by early fiscal 2026. We also took advantage of our low stock price during the second quarter and spent over $23 million repurchasing our shares.

“Overall, despite the challenging macroeconomic environment, we expect the seasonal uptick in demand we witnessed in the second quarter to continue through the summer, and we are confident in our ability to mitigate any potential margin impact related to tariffs. In addition, any unexpected weakness in demand in the second half of 2025 could be somewhat offset by the realization of cost synergies faster than originally planned. Our near-term priorities remain unchanged, which include staying focused on the Tyman integration, capturing synergies, and generating cash flow to repurchase our stock and pay down debt. Longer-term, we continue to expect that we will benefit from the release of pent-up demand as consumer confidence improves.”�

Second Quarter Results Summary

Quanex reported net sales of $452.5 million during the three months ended April 30, 2025, which represents an increase of 70.0% compared to $266.2 million for the same period of 2024. The increase reflects the contribution from the Tyman acquisition that closed on August 1, 2024. Excluding the contribution from Tyman, net sales would have declined by 1.4% for the second quarter of 2025, mainly due to lower volume in North America. The Company reported a decrease in net sales of 5.5% for the second quarter of 2025 in its North American Fenestration segment. In its North American Cabinet Components segment, Quanex reported a marginal increase in net sales for the second quarter of 2025. Excluding foreign exchange impact, net sales increased by 7.9% in its European Fenestration segment. In addition, Quanex reported net sales of $190.1 million related to the Tyman acquisition during the second quarter of 2025. (See Sales Analysis table for additional information)

The increase in net income and EBITDA for the three months ended April 30, 2025, was mostly related to the contribution from the Tyman acquisition combined with the realization of related cost synergies.

Balance Sheet & Liquidity Update

As of April 30, 2025, the Company had total debt of $785.0 million and Quanex’s leverage ratio of Net Debt to LTM Adjusted EBITDA decreased to 3.2x. As of April 30, 2025, the Company’s LTM Net Income was $17.1 million and LTM Adjusted EBITDA was $223.5 million (See Non-GAAP Terminology Definitions and Disclaimers section, Net Debt Reconciliation table and Last Twelve Months Adjusted EBITDA Reconciliation table for additional information)

The leverage ratio for Quanex’s quarterly debt covenant compliance (“Debt Covenant Leverage Ratio�) for its lenders was 2.7x as of April 30, 2025. The Debt Covenant Leverage Ratio calculation is defined in the Company’s Amendment No. 1 to its Second Amended and Restated Credit Agreement (“Credit Agreement�), which was filed with the SEC on June 12, 2024. In general, the main difference is that the Debt Covenant Leverage Ratio excludes real-estate leases that are considered “finance� leases under U.S. GAAP and is calculated on a proforma basis to include Adjusted EBITDA from the Tyman acquisition, $30 million of EBITDA for the synergy target related to the acquisition, less realized synergies, and only cash from domestic subsidiaries. Note that per the terms of the Credit Agreement, the quarterly Debt Covenant Leverage Ratio must be less than 3.75x through the fourth quarter of 2025 and less than 3.25x starting in the first fiscal quarter of 2026. The Debt Covenant Leverage Ratio would be 2.4x if calculated using the total cash and cash equivalents amount on the balance sheet as of April 30, 2024, and adjusting for the cash used to repurchase stock during the quarter.

Quanex’s liquidity was $289.0 million as of April 30, 2025, consisting of $62.6 million in cash on hand plus availability under its Senior Secured Revolving Credit Facility due 2029, less letters of credit outstanding.

Share Repurchases

Quanex’s Board authorized a $75 million share repurchase program in December of 2021. Repurchases under this program will be made in open market transactions or privately negotiated transactions, subject to market conditions, applicable legal requirements, and other relevant factors. The Company repurchased 1,259,407 shares of common stock for approximately $23.5 million at an average price of $18.66 per share during the three months ended April 30, 2025. As of April 30, 2025, approximately $35.6 million remained under the existing share repurchase authorization.

Outlook

Mr. Wilson stated, “Based on our results year-to-date, combined with our operational execution, cost synergy realization, recent demand trends, and conversations with our customers, we are once again reaffirming our guidance for fiscal 2025. On a consolidated basis for fiscal 2025, we continue to estimate that we will generate net sales of approximately $1.84 billion to $1.86 billion, which we expect will yield Adjusted EBITDA* of $270 million to $280 million.

“The finance and accounting teams continue to work with our external auditors on re-segmenting the business and our goal is to report in the new operating segments this year.�

*When Quanex provides expectations for Adjusted EBITDA on a forward-looking basis, a reconciliation of the differences between the non-GAAP expectations and corresponding GAAP measures is generally not available without unreasonable effort. Certain items required for such a reconciliation are outside of the Company’s control and/or cannot be reasonably predicted or estimated, such as the provision for income taxes related to net income.

Conference Call and Webcast Information

The Company has also scheduled a conference call for Friday, June 6, 2025 at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release. A link to the live audio webcast will be available on Quanex’s website at in the Investors section under Presentations & Events.

Participants can pre-register for the conference call using the following link:

Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, it is recommended that participants dial into the conference call ten minutes ahead of the scheduled start time. A replay will be available for a limited time on the Company’s website at in the Investors section under Presentations & Events.

About Quanex

Quanex is a global manufacturer with core capabilities and broad applications across various end markets. The Company currently collaborates and partners with leading OEMs to provide innovative solutions in the window, door, solar, refrigeration, custom mixing, building access and cabinetry markets. Looking ahead, Quanex plans to leverage its material science expertise and process engineering to expand into adjacent markets.

Non-GAAP Terminology Definitions and Disclaimers

Adjusted Net Income (defined as net income further adjusted to exclude amortization of step-up for purchase price adjustments on inventory, transaction, advisory fees and reorganization costs, restructuring charges related to severance and disposal of software, amortization expense related to intangible assets, pension settlement refund and other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflects operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net), Adjusted EBITDA and LTM Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making. Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex’s leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company’s credit agreement.

Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making. Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company’s residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company’s financial and cash management performance.

Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company’s financial performance when comparing results to other investment opportunities. The presented non-GAAP measures may not be the same as those used by other companies. Quanex does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with U.S. GAAP.

Forward Looking Statements

Statements that use the words “estimated,� “expect,� “could,� “should,� “believe,� “will,� “might,� or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: impacts from public health issues (including pandemics) on the economy and the demand for Quanex’s products, timing estimates or any other expectations related to the acquisition of Tyman, the Company’s future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to Quanex’s industry, and the Company’s future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from this release. For a complete discussion of factors that may affect Quanex’s future performance, please refer to the Company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2024, and the Company’s Quarterly Reports on Form 10-Q under the sections entitled “Cautionary Note Regarding Forward-Looking Statements� and “Risk Factors�. Any forward-looking statements in this press release are made as of the date hereof, and Quanex undertakes no obligation to update or revise any forward-looking statements to reflect new information or events.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)
(Unaudited)
Three Months Ended April 30,Six Months Ended April 30,
2025202420252024
Net sales$452,478$266,201$852,522$505,356
Cost of sales321,096199,963628,824387,686
Selling, general and administrative70,33334,707136,98367,070
Restructuring charges936-8,840-
Depreciation and amortization19,19210,89443,93222,046
Operating income40,92120,63733,94328,554
Interest expense(13,940)(950)(28,126)(2,018)
Other, net(159)41,0701,046
Income before income taxes26,82219,6916,88727,582
Income tax expense(6,307)(4,314)(1,257)(5,956)
Net income$20,515$15,377$5,630$21,626
Earnings per common share, basic$0.44$0.47$0.12$0.66
Earnings per common share, diluted$0.44$0.46$0.12$0.65
Weighted average common shares outstanding:
Basic46,48332,87046,75332,847
Diluted46,56333,10346,86833,076
Cash dividends per share$0.08$0.08$0.16$0.16


QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)
April 30, 2025October 31, 2024
ASSETS
Current assets:
Cash and cash equivalents$62,626$97,744
Restricted Cash2,1715,251
Accounts receivable, net195,264197,689
Inventories279,482275,550
Income taxes receivable6,1085,937
Prepaid and other current assets42,82529,097
Total current assets588,476611,268
Property, plant and equipment, net417,104402,466
Operating lease right-of-use assets149,322126,715
Deferred tax assets4,0493,845
Goodwill579,110574,711
Intangible assets, net567,148597,909
Other assets3,0572,874
Total assets$2,308,266$2,319,788
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable$112,484$124,404
Accrued liabilities91,573103,623
Income taxes payable-6,620
Current maturities of long-term debt26,12425,745
Current operating lease liabilities14,18412,475
Total current liabilities244,365272,867
Long-term debt746,387737,198
Noncurrent operating lease liabilities139,955117,560
Deferred income taxes163,591162,304
Other liabilities12,30519,113
Total liabilities1,306,6031,309,042
Stockholders� equity:
Common stock512513
Additional paid-in-capital698,238701,008
Retained earnings428,483430,405
Accumulated other comprehensive loss(27,034)(46,428)
Treasury stock at cost(98,536)(74,752)
Total stockholders� equity1,001,6631,010,746
Total liabilities and stockholders' equity$2,308,266$2,319,788


QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(In thousands)
(Unaudited)
Six Months Ended April 30,
20252024
Operating activities:
Net income$5,630$21,626
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization43,93222,046
Stock-based compensation1,8251,365
Deferred income tax1,250(155)
Other, net7,243162
Changes in assets and liabilities:
Decrease in accounts receivable5,32210,832
Increase in inventory(1,333)(3,008)
Increase in other current assets(7,828)(1,124)
Decrease in accounts payable(14,771)(12,619)
Decrease in accrued liabilities(14,048)(4,602)
(Decrease) increase in income taxes receivable(5,471)1,856
(Decrease) increase in other long-term liabilities(6,268)9
Other, net504557
Cash provided by operating activities15,98736,945
Investing activities:
Capital expenditures(26,544)(17,183)
Proceeds from disposition of capital assets37693
Cash used for investing activities(26,168)(17,090)
Financing activities:
Borrowings under credit facilities125,000-
Repayments of credit facility borrowings(117,500)(15,000)
Repayments of other long-term debt(1,888)(954)
Common stock dividends paid(7,552)(5,294)
Issuance of common stock214554
Payroll tax paid to settle shares forfeited upon vesting of stock(1,400)(1,193)
Purchase of treasury stock(27,194)-
Cash used for financing activities(30,320)(21,887)
Effect of exchange rate changes on cash and cash equivalents2,303(293)
Decrease in cash, cash equivalents and restricted cash(38,198)(2,325)
Cash, cash equivalents and restricted cash at beginning of period102,99558,474
Cash, cash equivalents and restricted cash at end of period$64,797$56,149


QUANEX BUILDING PRODUCTS CORPORATION
FREE CASH FLOW AND NET DEBT RECONCILIATION
(In thousands)
(Unaudited)
The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures.
Three Months Ended April 30,Six Months Ended April 30,
2025202420252024
Cash provided by operating activities$28,497$33,091$15,987$36,945
Capital expenditures(14,920)(7,603)(26,544)(17,183)
Free Cash Flow$13,577$25,488($10,557)$19,762
The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash.
As of April 30,
20252024
Term loan facility$481,205$0
Revolving credit facility242,500-
Finance lease obligations (1)61,27255,217
Total debt (2)784,97755,217
Less: Cash and cash equivalents62,62656,149
Net Debt$722,351($932)
(1) Includes $57.4 million and $51.0 million in real estate lease liabilities considered finance leases under U.S. GAAP as of April 30 2025 and 2024, respectively.
(2) Excludes outstanding letters of credit.


QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
LAST TWELVE MONTHS ADJUSTED EBITDA RECONCILIATION
(In thousands, except per share data)
(Unaudited)
Reconciliation of Last Twelve Months Adjusted EBITDAThree Months Ended
April 30, 2025
Three Months Ended
January 31, 2025
Three Months Ended
October 31, 2024
Three Months Ended
July 31, 2024
Total
ReconciliationReconciliationReconciliationReconciliationReconciliation
Net income (loss) as reported$20,515$(14,885)$(13,917)$25,350$17,063
Income tax expense (benefit)6,307(5,050)(3,621)6,6884,324
Other, net159(1,229)2,671(9,474)(7,873)
Interest expense13,94014,18617,69787846,701
Depreciation and amortization19,19224,74027,32910,95382,214
EBITDA60,11317,76230,15934,395142,429
Cost of sales (1)--8871,5072,394
Selling, general and administrative (1),(2),(3)86412,87650,0046,13369,877
Restructuring charges (4)9367,904--8,840
Adjusted EBITDA$61,913$38,542$81,050$42,035$223,540
(1) Expense (gain) related to plant closure.
(2) Transaction, advisory fees, and reorganization costs.
(3) Amortization of step-up for purchase price adjustments on inventory.
(4) Restructuring charges related to severeance and disposal of software.


QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
(In thousands, except per share data)
(Unaudited)
Reconciliation of Adjusted Net Income and Adjusted EPSThree Months Ended
April 30, 2025
Three Months Ended
April 30, 2024
Six Months Ended
April 30, 2025
Six Months Ended
April 30, 2024
Net IncomeDiluted EPSNet IncomeDiluted EPSNet IncomeDiluted EPSNet IncomeDiluted EPS
Net income as reported$20,515$0.44$15,377$0.46$5,630$0.12$21,626$0.65
Net income reconciling items from below7,372$0.168,664$0.2731,218$0.6710,680$0.33
Adjusted net income and adjusted EPS$27,887$0.60$24,041$0.73$36,848$0.79$32,306$0.98
Reconciliation of Adjusted EBITDAThree Months Ended
April 30, 2025
Three Months Ended
April 30, 2024
Six Months Ended
April 30, 2025
Six Months Ended
April 30, 2024
ReconciliationReconciliationReconciliationReconciliation
Net income as reported$20,515$15,377$5,630$21,626
Income tax (benefit) expense6,3074,3141,2575,956
Other, net159(4)(1,070)(1,046)
Interest expense13,94095028,1262,018
Depreciation and amortization19,19210,89443,93222,046
EBITDA60,11331,53177,87550,600
EBITDA reconciling items from below1,8008,49322,5798,698
Adjusted EBITDA$61,913$40,024$100,454$59,298
Reconciling ItemsThree Months Ended
April 30, 2025
Three Months Ended
April 30, 2024
Six Months Ended
April 30, 2025
Six Months Ended
April 30, 2024
Income StatementReconciling ItemsIncome StatementReconciling ItemsIncome StatementReconciling ItemsIncome StatementReconciling Items
Net sales$452,478$-$266,201$-$852,522$-$505,356$-
Cost of sales321,096-199,963(631)(1)628,824-387,686(631)(1)
Selling, general and administrative70,333(864)(2)34,707(7,862)(1),(2)136,983(13,739)(2),(3)67,070(8,067)(1),(2)
Restructuring charges936(936)(4)--8,840(8,840)(4)--
EBITDA60,1131,80031,5318,49377,87522,57950,6008,698
Depreciation and amortization19,192(6,451)(5)10,894(2,956)(5)43,932(17,101)(5)22,046(6,185)(5)
Operating income40,9218,25120,63711,44933,94339,68028,55414,883
Interest expense(13,940)-(950)-(28,126)-(2,018)-
Other, net(159)1,003(6)4(92)(6)1,070831(6)1,046(847)(6)
Income before income taxes26,8229,25419,69111,3576,88740,51127,58214,036
Income tax expense(6,307)(1,882)(7)(4,314)(2,693)(7)(1,257)(9,293)(7)(5,956)(3,356)(7)
Net income$20,515$7,372$15,377$8,664$5,630$31,218$21,626$10,680
Diluted earnings per share$0.44$0.46$0.12$0.65
(1) Expense (gain) related to plant closure.
(2) Transaction, advisory fees, and reorganization costs.
(3) Amortization of step-up for purchase price adjustments on inventory.
(4) Restructuring charges related to severeance and disposal of software.
(5) Amortization expense related to intangible assets.
(6) Pension settlement refund and foreign currency transaction losses (gains).
(7) Tax impact of net income reconciling items.


QUANEX BUILDING PRODUCTS CORPORATION
SELECTED SEGMENT DATA
(In thousands)
(Unaudited)
This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments.
NA FenestrationEU FenestrationNA Cabinet ComponentsTymanUnallocated Corp & OtherTotal
Three months ended April 30, 2025
Net sales$151,026$61,257$51,237$190,107$(1,149)$452,478
Cost of sales113,76039,00142,405126,743(813)321,096
Gross Margin37,26622,2568,83263,364(336)131,382
Gross Margin %24.7%36.3%17.2%33.3%29.0%
Selling, general and administrative (1)15,9389,0385,72537,2712,36170,333
Restructuring charges---936-936
Depreciation and amortization4,6672,6593,0158,7757619,192
Operating income (loss)16,66110,5599216,382(2,773)40,921
Depreciation and amortization4,6672,6593,0158,7757619,192
EBITDA21,32813,2183,10725,157(2,697)60,113
Transaction, advisory fees, and reorganization costs---675189864
Restructuring charges related to severance and disposal of software---936-936
Adjusted EBITDA$21,328$13,218$3,107$26,768$(2,508)$61,913
Adjusted EBITDA Margin %14.1%21.6%6.1%14.1%13.7%
Three months ended April 30, 2024
Net sales$159,774$56,583$51,078$-$(1,234)$266,201
Cost of sales122,26135,69442,624-(616)199,963
Gross Margin37,51320,8898,454-(618)66,238
Gross Margin %23.5%36.9%16.6%24.9%
Selling, general and administrative (1)13,7307,8735,066-8,03834,707
Depreciation and amortization5,2182,5383,082-5610,894
Operating income (loss)18,56510,478306-(8,712)20,637
Depreciation and amortization5,2182,5383,082-5610,894
EBITDA23,78313,0163,388-(8,656)31,531
Expense related to plant closure (Cost of sales)631----631
Expense related to plant closure (SG&A)978----978
Transaction and advisory fees----6,8846,884
Adjusted EBITDA$25,392$13,016$3,388$-$(1,772)$40,024
Adjusted EBITDA Margin %15.9%23.0%6.6%15.0%
Six months ended April 30, 2025
Net sales$285,359$109,728$95,047$365,783$(3,395)$852,522
Cost of sales220,32769,63881,821259,539(2,501)628,824
Gross Margin65,03240,09013,226106,244(894)223,698
Gross Margin %22.8%36.5%13.9%29.0%26.2%
Selling, general and administrative (1)32,07116,95910,99271,6495,312136,983
Restructuring charges---8,840-8,840
Depreciation and amortization9,4465,2696,02423,03815543,932
Operating income (loss)23,51517,862(3,790)2,717(6,361)33,943
Depreciation and amortization9,4465,2696,02423,03815543,932
EBITDA32,96123,1312,23425,755(6,206)77,875
Amortization of step-up for purchase price adjustments on inventory---9,007-9,007
Transaction, advisory fees, and reorganization costs---2,1422,5904,732
Restructuring charges related to severance and disposal of software---8,840-8,840
Adjusted EBITDA$32,961$23,131$2,234$45,744$(3,616)$100,454
Adjusted EBITDA Margin %11.6%21.1%2.4%12.5%11.8%
Six months ended April 30, 2024
Net sales$307,769$106,020$94,215$-$(2,648)$505,356
Cost of sales240,62967,39781,367-(1,707)387,686
Gross Margin67,14038,62312,848-(941)117,670
Gross Margin %21.8%36.4%13.6%23.3%
Selling, general and administrative (1)29,64015,61810,192-11,62067,070
Depreciation and amortization10,6935,0966,147-11022,046
Operating income (loss)26,80717,909(3,491)-(12,671)28,554
Depreciation and amortization10,6935,0966,147-11022,046
EBITDA37,50023,0052,656-(12,561)50,600
Expense related to plant closure (Cost of sales)631----631
Expense related to plant closure (SG&A)978----978
Transaction and advisory fees----7,0897,089
Adjusted EBITDA$39,109$23,005$2,656$-$(5,472)$59,298
Adjusted EBITDA Margin %12.7%21.7%2.8%11.7%
(1) Includes stock-based compensation expense for the three and six months ended April 30, 2025, respectively of $0.6 million and $1.8 million and $1.5 million and $4.1 million for the comparable prior year periods.


QUANEX BUILDING PRODUCTS CORPORATION
SALES ANALYSIS
(In thousands)
(Unaudited)
Three Months Ended April 30,Six Months Ended April 30,
2025202420252024
NA Fenestration:
United States - fenestration$112,261$119,646$212,690$231,280
International - fenestration8,0547,46513,91313,609
United States - non-fenestration26,75127,53249,95653,323
International - non-fenestration3,9605,1318,8009,557
$151,026$159,774$285,359$307,769
EU Fenestration: (1)
International - fenestration$50,687$46,968$92,743$88,719
International - non-fenestration10,5709,61516,98517,301
$61,257$56,583$109,728$106,020
NA Cabinet Components:
United States - fenestration$3,507$3,737$6,959$7,412
United States - non-fenestration47,36446,99087,42786,169
International - non-fenestration366351661634
$51,237$51,078$95,047$94,215
Tyman:
United States - fenestration$113,950$-$219,541$-
International - fenestration75,547-144,829-
United States - non-fenestration610-1,395-
International - non-fenestration--18-
$190,107$-$365,783$-
Unallocated Corporate & Other:
Eliminations$(1,149)$(1,234)$(3,395)$(2,648)
$(1,149)$(1,234)$(3,395)$(2,648)
Net Sales$452,478$266,201$852,522$505,356
(1) Reflects an increase of $0.2 million in revenue associated with foreign currency exchange rate impacts for the three and six months ended April 30, 2025, respectively.

FAQ

What were Quanex's (NX) Q2 2025 earnings results?

Quanex reported Q2 2025 net sales of $452.5M, net income of $20.5M, and diluted EPS of $0.44. Adjusted EBITDA was $61.9M with a margin of 13.7%.

How much cost synergy is expected from Quanex's Tyman acquisition?

Quanex increased its cost synergy target from the Tyman acquisition to approximately $45M, up from the original target of $30M, with expectations to achieve the initial $30M target by early fiscal 2026.

What is Quanex's (NX) financial guidance for fiscal 2025?

Quanex reaffirmed its fiscal 2025 guidance, projecting net sales of $1.84-1.86B and Adjusted EBITDA of $270-280M.

How much debt does Quanex (NX) currently have?

As of April 30, 2025, Quanex had total debt of $785.0M with a leverage ratio of Net Debt to LTM Adjusted EBITDA of 3.2x.

What was Quanex's (NX) share repurchase activity in Q2 2025?

Quanex repurchased 1,259,407 shares for approximately $23.5M at an average price of $18.66 per share, with $35.6M remaining under the existing authorization.
Quanex Build

NYSE:NX

NX Rankings

NX Latest News

NX Stock Data

996.24M
45.50M
1.03%
102.9%
3.57%
Building Products & Equipment
Rolling Drawing & Extruding of Nonferrous Metals
United States
HOUSTON